From: Expression of ADAMs and Their Inhibitors in Sputum from Patients with Asthma
Patients with asthma | Control subjects | |
---|---|---|
Sputum weight, g | 4.35 (1.43–8.92) | 3 (0.75–6.74) |
Viability, % | 92 (77–100) | 92 (71–100) |
Squamous cells, % | 10 (0–33) | 5 (0–13) |
Total nonsquamous cell, × 103/g | 1150 (260–25390) | 1457 (150–2180) |
Macrophages, % | 41.6 (4–83)a | 59.8 (25–76.4) |
Macrophages, × 103/g | 550 (85–5388) | 761 (334–1513) |
Eosinophils, % | 5.2 (0–67)a | 0.2 (0–7.2) |
Eosinophils, × 103/g | 59 (0–3555)a | 2.1 (0–94) |
Neutrophils, % | 23.2 (1.4–80.6) | 17 (5–55) |
Neutrophils, × 103/g | 343 (7–20464) | 187 (42–1150) |
Lymphocytes, % | 1.8 (0–5.2)a | 4.4 (0–13) |
Lymphocytes, ×103/g | 16 (0–196) | 45 (0–170) |
Epithelial cells, % | 8 (1.4–48.4) | 6.8 (1.8–33.2) |
Epithelial cells (103/g) | 145 (25–465) | 131 (32–375) |